Oakstone Intensive Review of Nephrology 2025

• Target Audience: clinical and academic nephrologists, internists, pediatricians, and primary care physicians/trainees
• Sample video: contact me for sample video
• Information:

New Release! Unmatched Board Prep and Nephrology Update

Genetic testing for improved diagnosis, prognosis and therapy selection

Introduction to point-of-care ultrasound: fundamentals for optimal image acquisition and accurate interpretation

Physical exam of the dialysis access

Further expansion of the roles of SGLT2i and finerenone in diabetic and non-diabetic kidney disease

New insights in immunology and the pathogenesis of glomerulonephritis

Novel immunosuppressive agents for glomerulonephritis

And more…

Date of Original Release: October 15, 2025

Estimated Time to Complete the Activity: 50.00 hours

Learning Objectives

Upon completion of this activity, participants will be able to:

Summarize current/recommended nephrology guidelines in clinical practice

Explain the differential diagnosis of complex clinical presentations of patients with renal disorders

Identify/integrate current therapeutic options for specific renal disorders

Describe pathophysiological mechanisms as they apply to management of renal disease

Synthesize teachings to better performance on the ABIM Nephrology certification/recertification examinations

Target Audience

• Topics:

Renal Physiology for the Boards – Melanie P. Hoenig, MD

Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD

Question and Answer Session – Faculty

Urine Sediment Analysis – Martina M. McGrath, MB BCh

Question and Answer Session – Faculty

Pathogenesis, Diagnosis, and Treatment of IgA Nephropathy – Gerald B. Appel, MD

Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD

Keynote – AI in Nephrology – Girish N. Nadkarni, MD, MPH, CPH

Question and Answer Session – Faculty

Treating Lupus Nephritis in 2025 – New Guidelines, New Medications, and New Challenges – Gerald B. Appel, MD

Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD

Anemia Management – Update and Best Practices – Brona M. Moloney, MBBCH, BAO, MMSc

Question and Answer Session – Faculty

Acid-Base Disorders Part I – Anion Gap Metabolic Acidosis – Alan S.L. Yu, MB, BChir

Acid-Base Disorders II – Non-Gap Acidosis and Metabolic Alkalosis – Alan S.L. Yu, MB, Bchir

Question and Answer Session – Faculty

Sodium Disorders – David B. Mount, MD

Potassium Disorders – David B. Mount, MD

Question and Answer Session – Faculty

Important New Trials in GN – David B. Mount, MD

Genetics and Kidney Disease – Friedhelm Hildebrandt, MD

Update on Polycystic Kidney Disease – Fouad T. Chebib, MD, FASN

Pediatric Nephrology – Michael J.G. Somers, MD

Genetics – How to Integrate It into Practice – Ana Onuchic-Whitford, MD

Diagnosis and Treatment of ANCA-associated Vasculitis – John L. Niles, MD

Question and Answer Session – Faculty

Why Do We Reject a Transplant? – Jamil R. Azzi, MD

Transplant Immunosuppression for the Boards – Brittany L. Schreiber, MD

Question and Answer Session – Faculty

Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD

Early Post-Transplant Management – Anil K. Chandraker, MD

Question and Answer Session – Faculty

Evaluation of the Living Donor Candidate – Kassem Safa, MD

Late Loss of the Kidney Transplant – Rania Khedher El Fekih, MD

Infections in Transplant Recipients – Barbra M. Blair, MD

Monitoring Kidney Transplant Patients – Beyond Creatinine – Jamil R. Azzi, MD

Pre-Transplant Surgical Evaluation of Recipients – Rania Khedher El Fekih, MD

Question and Answer Session – Faculty

Poisonings and Intoxications – What a Nephrologist Needs to Know – Charlotte E. Goldfine, MD

Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD

Hemolytic Uremic Syndrome (HUS) and Thrombotic Thrombocytopenic Purpura (TTP) – Jean M. Francis, MD

Geriatric Nephrology – Ernest I. Mandel, MD

Cardio-Renal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI

Management of Hypertension in CKD-Intensive or Standard Regimens – Richard J. Glassock, MD

Question and Answer Session – Faculty

Primary Aldosteronism – Anand Vaidya, MD, MMSc

Keynote – Climate Change, Global Inequities, and the Kidney – Valerie A. Luyckx, MBBCh, MSc, PhD

Liver and the Kidney – Andrew S. Allegretti, MD, MSc

Question and Answer Session – Faculty

Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD

Acute Kidney Injury Syndromes – Alice Sheridan, MD

ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh

Question and Answer Session – Faculty

Acute Kidney Injury in Cancer – Raad Chowdhury, MD

Paraprotein-Induced Kidney Injury – Raad Chowdhury, MD

Therapy of Focal and Segmental Glomerulosclerosis (FSGS) Lesions in 2025 – Richard J. Glassock, MD

Pathophysiology and Treatment of Diabetic Kidney Disease – Gearoid M. McMahon, MB BCh

APOL1 and Kidney Disease – Opeyemi Olabisi, MD, PhD

Question and Answer Session – Faculty

Patient Perspective – Dialysis Dosing – Moderators – J. Kevin Tucker, MD and Paul Moore; Dialysis Patients – Daphne Rhodes and Vanessa Evans

Chronic Kidney Disease – Mineral and Bone Disease – David Bushinsky, MD

Question and Answer Session – Faculty

Chronic Kidney Disease – Mineral and Bone Disease Case-Based Pearls – David Bushinsky, MD

Chronic Kidney Disease Epidemiology – Gearoid M. McMahon, MB BCh

Question and Answer Session – Faculty

Introduction to Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC

Complications of Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC

Acute Kidney Injury Related to Immune Checkpoint Inhibitors – Shruti Gupta, MD

Question and Answer Session – Faculty

Mesoamerican Nephropathy – David J. Friedman, MD

Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD

Dialysis Vascular Access – Assessment and Complications – Dirk M. Hentschel, MD

Question and Answer Session – Faculty

Glomerulonephritis – Questions & Answers Session – Gerald B. Appel, MD

Must-Know Clinical Images in Nephrology – Annie Liu, DO, MPH, MS

Electrolytes and Acid-Base Practice for the Boards – Part 1 – Alan S.L. Yu, MB, Bchir

Electrolytes and Acid-Base Practice for the Boards – Part 2 – Alan S.L. Yu, MB, Bchir

Chronic Kidney Disease in the Community – Leveraging Resources Effectively, Lessons Learned from KDSAP – Li-Li Hsiao, MD, PhD, FACP

COVID-19 Vaccination in Immunocompromised Patients – Ann Woolley, MD

Update on Renovascular Disease – Joseph M. Garasic, MD

Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD

Immunologic Basis of Kidney Disease – Vivek Kasinath, MD

Use of Checkpoint Inhibitors in Kidney Transplant Recipients – Naoka Murakami, MD, PhD

Interstitial Nephritis – Overview for the Boards – Julie M. Paik, MD, ScD, MPH

Ethics in Nephrology – Valerie Luyckx, MD, MB BCh

Pregnancy and Renal Disease – Jessica Tangren, MD

Must-Know Board Zebras – Emily Robinson, MD, MPH